Halozyme Therapeutics (HALO) Technical (Analysis) Reports Halozyme Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Halozyme Therapeutics (HALO)
Technical Analysis Report for NASDAQ stock HALO Halozyme Therapeutics. Dated: 10 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock HALO Halozyme Therapeutics then click here. or read Experts views on Halozyme Therapeutics or Forecast & share price targets of Halozyme Therapeutics
Halozyme Therapeutics Opened at 78.50 and Closed at: 76.19, which is -3.24% of previous session's close. It moved within a range of 75.33 and 79.19
The session was a Bearish session with an average volume of 800541, which is -65.3% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
Support for tomorrow is 73.83 and resistance for tomorrow is 77.69
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 74.62, 73.04 resistance for tomorrow's hourly charts is 78.48, 80.76
10 Day SMA for Halozyme Therapeutics (HALO) is 78.44 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Halozyme Therapeutics (HALO) is 74.26 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Halozyme Therapeutics (HALO) is 70.46 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 68.64 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Halozyme Therapeutics is 69.19 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Halozyme Therapeutics is at 74.26 and 200 DMA is at 69.19, while 50 DMA and 100 DMA are at 70.46 and 68.64 respectively
Halozyme Therapeutics (HALO) moving average of 20 SMA is at 74.26 and 20 EMA is at 75.38
| Date | Closing Price | 20 SMA | 20 EMA |
| 10 Fri Jul | 76.19 | 74.26 | 75.38 |
| 09 Thu Jul | 78.66 | 73.97 | 75.29 |
| 08 Wed Jul | 80.37 | 73.61 | 74.93 |
| 07 Tue Jul | 81.57 | 73.13 | 74.36 |
| 06 Mon Jul | 80.78 | 72.63 | 73.6 |
| 02 Thu Jul | 79.45 | 72.17 | 72.84 |
Halozyme Therapeutics (HALO) moving average of 50 SMA is at 70.46 and 50 EMA is at 71.96
| Date | Closing Price | 50 SMA | 50 EMA |
| 10 Fri Jul | 76.19 | 70.46 | 71.96 |
| 09 Thu Jul | 78.66 | 70.2 | 71.79 |
| 08 Wed Jul | 80.37 | 69.9 | 71.51 |
| 07 Tue Jul | 81.57 | 69.59 | 71.15 |
| 06 Mon Jul | 80.78 | 69.26 | 70.73 |
| 02 Thu Jul | 79.45 | 68.98 | 70.32 |
Halozyme Therapeutics (HALO) moving average of 100 SMA is at 68.64 and 100 EMA is at 70.25
| Date | Closing Price | 100 SMA | 100 EMA |
| 10 Fri Jul | 76.19 | 68.64 | 70.25 |
| 09 Thu Jul | 78.66 | 68.68 | 70.13 |
| 08 Wed Jul | 80.37 | 68.68 | 69.96 |
| 07 Tue Jul | 81.57 | 68.65 | 69.75 |
| 06 Mon Jul | 80.78 | 68.63 | 69.51 |
| 02 Thu Jul | 79.45 | 68.62 | 69.28 |
Halozyme Therapeutics (HALO) moving average of 200 SMA is at 69.19 and 200 EMA is at 68.3
| Date | Closing Price | 200 SMA | 200 EMA |
| 10 Fri Jul | 76.19 | 69.19 | 68.3 |
| 09 Thu Jul | 78.66 | 69.2 | 68.22 |
| 08 Wed Jul | 80.37 | 69.2 | 68.11 |
| 07 Tue Jul | 81.57 | 69.18 | 67.99 |
| 06 Mon Jul | 80.78 | 69.16 | 67.85 |
| 02 Thu Jul | 79.45 | 69.13 | 67.72 |
Xencor Inc has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Xencor Inc, about 23.46% more returns!
Bio Techne has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Bio Techne, about 24.25% more returns!
Sellas Life has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Sellas Life, about 56.8% more returns!
Neurocrine Biosciences has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Neurocrine Biosciences, about 1.18% more returns!
Mesoblast has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Mesoblast, about 1.77% more returns!
Liquidia Technologies has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Liquidia Technologies, about 1.12% more returns!
Halozyme Therapeutics has performed better than Lakeland Industries in short term. Holding Halozyme Therapeutics could be a better choice for now!
Orthopediatrics Corp has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Orthopediatrics Corp, about 6.36% more returns!
Halozyme Therapeutics has performed better than Kala Pharmaceuticals in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Aptorum Group in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Biolife Solutions in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Capricor Therapeutics in short term. Holding Halozyme Therapeutics could be a better choice for now!
Compugen has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Compugen, about 9.44% more returns!
Halozyme Therapeutics has performed better than Cogentix Medical in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Establishment Labs in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Exelixis Inc in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Gilead Sciences in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Grifols S in short term. Holding Halozyme Therapeutics could be a better choice for now!
Healthcare Services has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Healthcare Services, about 2.47% more returns!
Halozyme Therapeutics Technical analysis of indicators
Price action analysis of Halozyme Therapeutics (HALO) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Halozyme Therapeutics in short term and the buy signal is strong.
Halozyme Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Halozyme Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 78.34 and Halozyme Therapeutics HALO stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Halozyme Therapeutics HALO stock. Volume based technical analysis of Halozyme Therapeutics HALO stock is negative.
Halozyme Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock HALO Halozyme Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And HALO Experts View which covers a lot of information including buying and selling signals
HALO future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Halozyme Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Halozyme Therapeutics (HALO) Technical (Analysis) Reports Halozyme Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


